Home  |  Contact

UniProtKB/Swiss-Prot P12883: Variant p.Gly425Arg

Myosin-7
Gene: MYH7
Variant information

Variant position:  425
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Arginine (R) at position 425 (G425R, p.Gly425Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CMH1.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  425
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1935
The length of the canonical sequence.

Location on the sequence:   KVGNEYVTKGQNVQQVIYAT  G ALAKAVYERMFNWMVTRINA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KVGNEYVTKGQNVQQVIYATGALAKAVYERMFNWMVTRINA

                              KVGNEYVTKGQNVQQVAYATGALAKAVYEKMFNWMVTRINA

Mouse                         KVGNEYVTKGQNVQQVSYAIGALAKSVYEKMFNWMVTRINA

Rat                           KVGNEYVTKGQNVQQVAYAIGALAKSVYEKMFNWMVTRINA

Pig                           KVGNEYVTKGQNVQQVMYATGALAKAVYEKMFNWMVTRINT

Bovine                        KVGNEYVTKGQNVQQVVYAKGALAKAVYERMFNWMVTRINA

Horse                         KVGNEYVTKGQNVQQVAYAKGALAKAVYERMFNWMVARINA

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1935 Myosin-7
Domain 85 – 778 Myosin motor
Helix 417 – 447


Literature citations

Mutations profile in Chinese patients with hypertrophic cardiomyopathy.
Song L.; Zou Y.; Wang J.; Wang Z.; Zhen Y.; Lou K.; Zhang Q.; Wang X.; Wang H.; Li J.; Hui R.;
Clin. Chim. Acta 351:209-216(2005)
Cited for: VARIANTS CMH1 VAL-26; GLN-143; ARG-425; THR-450; PHE-511; GLN-615; CYS-663; HIS-663; PRO-734; ARG-741; THR-822; GLU-823; HIS-858; LYS-924 AND LYS-930;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.